Abstract: Disclosed is a composition for preventing and treating acetaminophen induced liver injury including the protein extracted from Porphyra yezoensis. The protein(s), separated and purified from hot water extracts of Porphyra yezoensis, having the molecular weight of 14 kDa measured by sodium dodecyl sulfate polyacrylamide gel electrophoresis, has an excellent effect for inhibiting the oxidative injury of liver tissue and cell apoptosis of liver cells induced by acetaminophen.

Abstract: An automated and computerized system for characterizing kinetic activities is disclosed. The system includes an optical unit with a controller chip. The controller chip has multiple reaction cells for simultaneously reacting samples of the catalyst under a range of reaction conditions and for optically monitoring the kinetic activity within each of the reaction cells: The system also preferably includes a temperature controller in thermal contact with the controller chip and an actuation device coupled to the controller chip for injecting and mixing samples of the catalyst with reagents into each of the reaction cells to form a product.

Abstract: The present invention relates to a composition for preventing and treating acetaminophen induced liver injury comprising the protein extracts from porphyra yezoensis. The protein separated and purified from hot water extracts of porphyra yezoensis and having the molecular weight of 14 kDa measured by sodium dodecyl sulfate polyacrylamide gel electrophoresis manner has an excellent effect for inhibiting the oxidative injury of the liver tissue and the cell apoptosis of the liver cell induced by acetaminophen.

Abstract: An automated and computerized system for characterizing kinetic activities is disclosed. The system includes an optical unit with a controller chip. The controller chip has multiple reaction cells for simultaneously reacting samples of the catalyst under a range of reaction conditions and for optically monitoring the kinetic activity within each of the reaction cells. The system also preferably includes a temperature controller in thermal contact with the controller chip and an actuation device coupled to the controller chip for injecting and mixing samples of the catalyst with reagents into each of the reaction cells to form a product.

Abstract: An automated and computerized system for characterizing kinetic activities is disclosed. The system includes an optical unit with a controller chip. The controller chip has multiple reaction cells for simultaneously reacting samples of the catalyst under a range of reaction conditions and for optically monitoring the kinetic activity within each of the reaction cells; The system also preferably includes a temperature controller in thermal contact with the controller chip and an actuation device coupled to the controller chip for injecting and mixing samples of the catalyst with reagents into each of the reaction cells to form a product.

Abstract: Disclosed is a polymannuronate composition including polymannuronate having molecular weight from about 4,000 to about 500,000 in a high purity. The composition can be used in producing nutritional compositions such as functional foods and health aids. Also, the composition can be used in a pharmaceutical composition along with a pharmaceutical carrier. The composition has various effects, including controlling serum lipids, preventing hyperlipidemia, preventing obesity, preventing diabetes, enhancing functions of liver, expelling heavy metals from a body, etc. Further disclosed is a process to producing the polymannuronate composition, in which alginate is hydrolyzed and then the polymannuronate components are isolated. Further disclosed herein is a composition produced by that process. In the hydrolysis, an organic acid is preferably used, and the isolation of the polymannuronate involves adjustment of pH of the resulting mixture of the hydrolysis.

Abstract: Disclosed is a polymannuronate composition including polymannuronate having molecular weight from about 4,000 to about 500,000 in a high purity. The composition can be used in producing nutritional compositions such as functional foods and health aids. Also, the composition can be used in a pharmaceutical composition along with a pharmaceutical carrier. The composition has various effects, including controlling serum lipids, preventing hyperlipidemia, preventing obesity, preventing diabetes, enhancing functions of liver, expelling heavy metals from a body, etc. Further disclosed is a process to producing the polymannuronate composition, in which alginate is hydrolyzed and then the polymannuronate components are isolated. Further disclosed herein is a composition produced by that process. In the hydrolysis, an organic acid is preferably used, and the isolation of the polymannuronate involves adjustment of pH of the resulting mixture of the hydrolysis.